10/31/14 NUVA 40.90 Nuvasive Inc $NUVA Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
10/31/14 NUVA 40.90 Nuvasive Inc $NUVA Hit a 52 week high of 42.44 Closing the day 10/31/14 at 40.90 +1.64 +4.18% With a day low of 40.00 and a total volume of 921,100.

NUVA Recent Posts: http://investorshangout.com/NuVasive-Inc-NUVA-54931/

NUVA Nuvasive Inc Recent Headline News

NuVasive Reports Third Quarter 2014 Financial Results and Increases Full Year Guidance
Marketwired - Thu Oct 30, 3:07PM CDT
NuVasive, Inc. (NASDAQ: NUVA)
NUVA: 40.90 (+1.64)

NuVasive Announces Conference Call and Webcast of Third Quarter 2014 Results
Marketwired - Thu Oct 16, 3:30PM CDT
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that its third quarter 2014 earnings announcement will take place on Thursday, October 30, 2014, after the close of the market.
NUVA: 40.90 (+1.64)

Insider Trading Alert - REX, NVAX And NUVA Traded By Insiders
at The Street - Tue Oct 07, 10:54AM CDT
Stocks with insider trader activity include REX, NVAX and NUVA
NVAX: 5.60 (-0.03), REX: 72.76 (+2.46), NUVA: 40.90 (+1.64)

NuVasive(R) Demonstrates Expanding EMEA Business at Eurospine 2014 With Surgeon Workshops and Innovative Product Exhibition
Thomson Reuters ONE - Wed Oct 01, 7:31AM CDT
Product Demonstrations and Spine Procedure Workshops Highlight Commitment to Serving the Needs of Patients and Surgeons in Europe; Company Also Announces Opening of New European Center of Excellence in Amsterdam
NUVA: 40.90 (+1.64)

Will This Analyst Upgrade Help NuVasive (NUVA) Stock Today?
at The Street - Tue Sep 30, 8:31AM CDT
Brean Capital upgraded NuVasive (NUVA) to 'buy' from 'hold' and set a $44 price target.
NUVA: 40.90 (+1.64)

Upgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Tue Sep 30, 7:07AM CDT
NuVasive (NASDAQ:NUVA) was upgraded from Hold to Buy at Brean Capital today. The stock closed yesterday at $35.02 on volume of 139,000 shares, below average daily volume of 256,000. NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
NUVA: 40.90 (+1.64)

St. Jude Medical Gets Award for Leadless Pacemaker Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 12:50PM CDT
In June this year, St. Jude Medical (STJ) had received the 2014 Innovation Award at Cardiostim 2014 ??? the 19th World Congress in Cardiac Electrophysiology and Cardiac Techniques ??? for its Nanostim leadless pacemaker.
ICUI: 70.90 (unch), SMA: 9.90 (+0.16), STJ: 64.17 (-0.11), NUVA: 40.90 (+1.64)

Is Abaxis (ABAX) a Buy After Solid Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 3:50PM CDT
On Sep 5, 2014, we issued an updated research report on Abaxis Inc. (ABAX).
MWIV: 169.65 (+3.85), ABAX: 52.66 (+1.13), EGRX: 12.67 (-0.13), NUVA: 40.90 (+1.64)

Symmetry Medical Updates on OEM Solutions Divestment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 12:40PM CDT
According to Symmetry Medical (SMA), the proposed sale will recognize the value of the OEM Solutions business and enhance the growth potential of Symmetry Surgical.
ICUI: 70.90 (unch), SMA: 9.90 (+0.16), ABAX: 52.66 (+1.13), NUVA: 40.90 (+1.64)

NuVasive Spine Foundation(TM) Exceeds $13 Million in Global Effort to Support Patients in Need
Marketwire - Mon Sep 08, 9:37AM CDT
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is proud to announce today that the NuVasive Spine Foundation(TM) (NSF), a non-profit organization founded and managed by NuVasive, has reached a cumulative milestone of more than $13 million contributed since the Foundation's inception in 2009. To date, NuVasive has donated approximately $10.5 million in surgical products. The announcement follows the successful completion of the Seventh Annual NuVasive Spine Foundation San Diego Golf Tournament held at the Maderas Golf Club on August 24, 2014.
NUVA: 40.90 (+1.64)

Insider Trading Alert - REX, PSEC And NUVA Traded By Insiders
at The Street - Thu Sep 04, 9:05AM CDT
Stocks with insider trader activity include REX, PSEC and NUVA
REX: 72.76 (+2.46), NUVA: 40.90 (+1.64), PSEC: 9.58 (-0.05)

Baxter Expects to Grow on Acquisitions and Product Lineups - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 12:10PM CDT
Baxter International (BAX) operates in the life-sustaining and critical care products category that should remain relatively insulated from economic downturns.
ICUI: 70.90 (unch), BAX: 70.14 (+0.08), NEOG: 43.90 (-0.14), NUVA: 40.90 (+1.64)

MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
ABMD: 32.79 (+1.44), BDX: 128.70 (+1.18), MDT: 68.16 (+0.73), ARAY: 6.33 (+0.11), NUVA: 40.90 (+1.64), CYBX: 52.50 (+1.77), BSX: 13.28 (+0.10), JNJ: 107.78 (+0.74), ICUI: 70.90 (unch), WMGI: 31.62 (-0.16), OPK: 8.35 (-0.04), RMD: 52.22 (+0.11), ABBV: 63.46 (+2.28), SYK: 87.53 (+0.49), ZMH: 111.24 (+1.96), ABT: 43.59 (+0.10), SMA: 9.90 (+0.16), BCR: 163.97 (+2.98), MCK: 203.41 (-0.07), TMO: 117.57 (+0.98), PFE: 29.95 (+0.11), COV: 92.44 (+0.83), EW: 120.92 (+0.64), MYL: 53.55 (+1.18), COO: 163.90 (+0.24), CG: 27.76 (+0.20), ABAX: 52.66 (+1.13), BAX: 70.14 (+0.08), DGX: 63.46 (-0.02), STJ: 64.17 (-0.11), THOR: 27.18 (+0.78), HGR: 23.93 (+0.40)

MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
ABMD: 32.79 (+1.44), BDX: 128.70 (+1.18), MDT: 68.16 (+0.73), ARAY: 6.33 (+0.11), NUVA: 40.90 (+1.64), CYBX: 52.50 (+1.77), BSX: 13.28 (+0.10), JNJ: 107.78 (+0.74), ICUI: 70.90 (unch), WMGI: 31.62 (-0.16), OPK: 8.35 (-0.04), RMD: 52.22 (+0.11), ABBV: 63.46 (+2.28), SYK: 87.53 (+0.49), ZMH: 111.24 (+1.96), ABT: 43.59 (+0.10), SMA: 9.90 (+0.16), BCR: 163.97 (+2.98), MCK: 203.41 (-0.07), TMO: 117.57 (+0.98), PFE: 29.95 (+0.11), COV: 92.44 (+0.83), EW: 120.92 (+0.64), MYL: 53.55 (+1.18), COO: 163.90 (+0.24), CG: 27.76 (+0.20), ABAX: 52.66 (+1.13), BAX: 70.14 (+0.08), DGX: 63.46 (-0.02), STJ: 64.17 (-0.11), THOR: 27.18 (+0.78), HGR: 23.93 (+0.40)

MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews
ABMD: 32.79 (+1.44), BDX: 128.70 (+1.18), MDT: 68.16 (+0.73), ARAY: 6.33 (+0.11), NUVA: 40.90 (+1.64), CYBX: 52.50 (+1.77), BSX: 13.28 (+0.10), JNJ: 107.78 (+0.74), ICUI: 70.90 (unch), WMGI: 31.62 (-0.16), OPK: 8.35 (-0.04), RMD: 52.22 (+0.11), ABBV: 63.46 (+2.28), SYK: 87.53 (+0.49), ZMH: 111.24 (+1.96), ABT: 43.59 (+0.10), SMA: 9.90 (+0.16), BCR: 163.97 (+2.98), MCK: 203.41 (-0.07), TMO: 117.57 (+0.98), PFE: 29.95 (+0.11), COV: 92.44 (+0.83), EW: 120.92 (+0.64), MYL: 53.55 (+1.18), COO: 163.90 (+0.24), CG: 27.76 (+0.20), ABAX: 52.66 (+1.13), BAX: 70.14 (+0.08), DGX: 63.46 (-0.02), STJ: 64.17 (-0.11), THOR: 27.18 (+0.78), HGR: 23.93 (+0.40)

ResMed Continues to Disappoint despite OSA Market Potential - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 3:45PM CDT
On Aug 25, 2014, we issued an updated research report on ResMed, Inc. (RMD).
ICUI: 70.90 (unch), ABAX: 52.66 (+1.13), RMD: 52.22 (+0.11), NUVA: 40.90 (+1.64)

Symmetry Medical Shows Stability on Bottom Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 1:50PM CDT
Symmetry Medical's (SMA) divestment of its U.K. based subsidiary, Clamonta Ltd. on May 22, 2014 was also in sync with its plans to focus on its core markets and reduce its manufacturing footprint
ICUI: 70.90 (unch), SMA: 9.90 (+0.16), ABAX: 52.66 (+1.13), NUVA: 40.90 (+1.64)

Earnings Look Back: NuVasive Is Up 1.3% Since Reporting Quarterly Results 2 Weeks Ago (NUVA)
Comtex SmarTrend(R) - Mon Aug 18, 9:05AM CDT
When NuVasive (NASDAQ:NUVA) reported earnings two weeks ago on July 29th, 2014, analysts, on average, expected the company to report earnings of $0.25 on sales of $177.4 million. NuVasive actually reported earnings of $0.28 per share on sales of $190.7 million, beating EPS estimates by $0.03 and beating revenue estimates by $13.3 million. Shares of NuVasive have climbed from $35.06 to $35.52, representing a gain of 1.3% since the company reported earnings 20 days ago.
NUVA: 40.90 (+1.64)

NuVasive Inc. (NUVA) Stock Research Links

NUVA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cadence Marks $2.7 Million for St. Jude Family Care

Updated Category News Views 93

Small Wheels, Serious Purpose Tiny tricycles, flour-dusted bake-sale tables, and family pledges have pushed Cadence Education’s St. Jude partnership to $2.7 million since 2018. That number is not a flashy balance-sheet item, nor should anybody try to dress it up as one. It is the accumulated result of school communities showing up year after year, and in a sector built...

Continue Reading
Qonto's Banking License Raises the Stakes in Europe

Updated Category News Views 100

A regulatory stamp can look dull on paper, yet this one changes the machinery underneath Qonto. The Paris-based finance platform has received a Credit Institution license from France's ACPR and the European Central Bank, giving it a route to offer broader lending and savings products directly to small and midsize businesses across Europe. That is a serious corporate...

Continue Reading
ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 181

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading
Rehab Equipment Growth Meets a Brutal Access Gap

Updated Category News Views 27

Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 204

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Cedar’s Fast 500 Spot Shows Billing Tech’s Momentum

Updated Category News Views 26

A 486th-place finish can look like the last seat on the bus, but Cedar’s 102% revenue growth from 2022 through 2025 is not nothing. Healthcare billing is a miserable, deeply entrenched corner of the economy where legacy systems have had decades to dig in. Growing at all while selling technology into health systems deserves a serious look, even if nobody should confuse a...

Continue Reading
Another Nine's A9OS Puts Software at Center of Golf

Updated Category News Views 9

A golf simulator chain is trying to turn the boring plumbing into its sharpest club. Another Nine’s A9OS is not merely a booking widget dressed up for a franchise brochure; it is meant to run the whole 24/7 operation, from payments and door access to cameras, simulator support and guest help. That ambition deserves attention because this is exactly where a staff-free...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 59

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 267

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Albany Masonry Waterproofing Is a Quiet Value Play

Updated Category News Views 74

Winter works its mischief one soaked brick at a time. That is the unglamorous truth behind Sean Mulligan's discussion of masonry waterproofing for Albany-area homes. Brick and stone look tough enough to outlast the furniture, the siding, maybe the whole neighborhood. Yet they are porous materials, and in a region where rain, snowmelt, and sharp temperature swings keep...

Continue Reading

Top 5 Most Recently Viewed Articles

Ping An Healthcare Delivers Impressive Growth in Interim Results

Updated Category News Views 186

Impressive Interim Results from Ping An Healthcare Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) has announced robust interim results for the six-month period ending June 30, showing significant progress following its return to profitability. Throughout this period, the Company has demonstrated strong revenue growth and a notable...

Continue Reading
Market Insights: Trends in Precious Metals and Sector Performance

Updated Category News Views 201

Understanding Market Dynamics and Precious Metals The current landscape of Wall Street might appear quiet at first glance, especially during the lull between holidays. However, beneath this surface lies a surge of activity, particularly in the realm of precious metals. Investors are keenly observing the uptick in volatility, specifically concerning silver and other key...

Continue Reading
Discover the Most Popular Pet Breeds of 2025: Insights and Trends

Updated Category News Views 409

Understanding the 2025 Top Pet Breeds The bond between pets and their owners often mirrors our own personalities and values. Recent insights reveal that 8 out of 10 pet parents believe a dog breed reflects a person's character. Across different breeds, qualities such as friendliness, sociability, and playfulness top the charts when pet parents make their choices. The...

Continue Reading
Amicus Therapeutics Engages Investors at Key Conferences Soon

Updated Category News Views 129

Amicus Therapeutics to Present at Upcoming Investor Conferences Amicus Therapeutics (Nasdaq: FOLD), a dedicated player in the biotechnology landscape, has announced its forthcoming participation in significant investor conferences this September, showcasing its unwavering commitment to fostering investor relations. Details of the Upcoming Presentations The company has...

Continue Reading
Understanding RPM Intl's P/E Ratio in Market Context

Updated Category News Views 206

Understanding RPM Intl's Stock Performance Currently, RPM Intl Inc. (NYSE: RPM) is experiencing a share price of $123.50, reflecting a modest increase of 0.36%. This uptick is notable amidst a turbulent month, where the stock has decreased by 11.21%. However, when we look back over the past year, we see a positive trend, with the stock appreciating by 16.26%. Investors...

Continue Reading